$265m

Bloomberg Businessweek (North America) - - Mar­kets/Fi­nance -

As­trazeneca sells its gout drug. Iron­wood Phar­ma­ceu­ti­cals bought the U.S. rights to Zu­rampic, a newly ap­proved treat­ment. The deal gives As­trazeneca roy­al­ties on fu­ture sales.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.